Skip navigation
Use este identificador para citar ou linkar para este item: http://repositorio2.unb.br/jspui/handle/10482/39872
Arquivos associados a este item:
Arquivo Descrição TamanhoFormato 
ARTIGO_SARS-CoV-2Covid-19Search.pdf291,61 kBAdobe PDFVisualizar/Abrir
Registro completo de metadados
Campo DCValorIdioma
dc.contributor.authorAraújo, Joabe Lima-
dc.contributor.authorAzevedo, Vitória Santos-
dc.contributor.authorAraújo, Adrielle de Sá-
dc.contributor.authorAraújo, Jessé Lima-
dc.contributor.authorAraújo, Ingryde Lima-
dc.contributor.authorSousa, Lucas Aires de-
dc.contributor.authorSantos, Gardênia Taveira-
dc.contributor.authorSilva, Welson de Freitas-
dc.contributor.authorPinheiro, Ana Maria Alves-
dc.contributor.authorSantos, Gabel Taveira-
dc.contributor.authorCruz, Hugo Vitor Menezes-
dc.contributor.authorPassos, Ionara Nayana Gomes-
dc.contributor.authorRocha, Jefferson Almeida-
dc.date.accessioned2021-01-08T19:40:31Z-
dc.date.available2021-01-08T19:40:31Z-
dc.date.issued2020-06-30-
dc.identifier.citationARAÚJO. Joabe Lima et al. SARS-CoV-2 or Covid-19: the search for alternative treatment for the new coronavirus. International Journal of Development Research, v. 10, n. 06, p. 37117-37122, jun. 2020. DOI: https://doi.org/10.37118/ijdr.19286.06.2020. Disponível em: http://www.journalijdr.com/sars-cov-2-or-covid-19-search-alternative-treatment-new-coronavirus. Acesso em: 08 jan. 2021.pt_BR
dc.identifier.urihttps://repositorio.unb.br/handle/10482/39872-
dc.language.isoInglêspt_BR
dc.publisherInternational Journal of Development Researchpt_BR
dc.rightsAcesso Abertopt_BR
dc.titleSARS-CoV-2 or Covid-19 : the search for alternative treatment for the new coronaviruspt_BR
dc.typeArtigopt_BR
dc.subject.keywordSARS-CoV-2pt_BR
dc.subject.keywordCoronaviruspt_BR
dc.subject.keywordEpidemiaspt_BR
dc.subject.keywordCovid-19pt_BR
dc.subject.keywordTratamentopt_BR
dc.subject.keywordMedicamentospt_BR
dc.subject.keywordVacinaspt_BR
dc.rights.licenseCopyright © 2020, Joabe Lima Araújo et al., 2020. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.pt_BR
dc.identifier.doihttps://doi.org/10.37118/ijdr.19286.06.2020pt_BR
dc.description.abstract1SARS-CoV-2 belongs to the Coronaviridae family and of the order Nidovirales, which has positive non-segmented RNA, of the enveloped type that causes a severe acute respiratory syndrome in humans, which has already infected more than 9 million people worldwide, leading to 496,075 deaths by June 27, 2020, making the search for alternative treatment for this pathogen urgent. Thus, this study aimed to conduct a bibliographic survey of research that presents treatment alternatives for the new coronavirus. Thus, a qualitative and descriptive cross-sectional study was carried out, and a comparative analysis was carried out with the prospective results achieved as presented in a study carried out by Reis and collaborators. Publications from the last 7 months were considered, that is, from December 2019 to June 2020, the period in which studies of SARS-CoV-2 started. In this way, a total of 4,898 studies related to the treatment alternative for SARS-CoV-2 were found, in which the drugs remdesivir, atazanavir, favipiravir, EIDD-2801 and hydroxychloroquine associated with azithromycin stand out, where they presented attractive preliminary results and are recommended for clinical studies in humans as an alternative way of coping with the new coronavirus.pt_BR
Aparece nas coleções:Artigos publicados em periódicos e afins
UnB - Covid-19

Mostrar registro simples do item Visualizar estatísticas



Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.